These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 31280020)
1. Novel N-benzylpiperidine carboxamide derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer's disease. van Greunen DG; Johan van der Westhuizen C; Cordier W; Nell M; Stander A; Steenkamp V; Panayides JL; Riley DL Eur J Med Chem; 2019 Oct; 179():680-693. PubMed ID: 31280020 [TBL] [Abstract][Full Text] [Related]
2. Targeting Alzheimer's disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil. van Greunen DG; Cordier W; Nell M; van der Westhuyzen C; Steenkamp V; Panayides JL; Riley DL Eur J Med Chem; 2017 Feb; 127():671-690. PubMed ID: 27823887 [TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of N-benzylpiperidine-purine derivatives as new dual inhibitors of acetyl- and butyrylcholinesterase. Rodríguez-Franco MI; Fernández-Bachiller MI; Pérez C; Castro A; Martínez A Bioorg Med Chem; 2005 Dec; 13(24):6795-802. PubMed ID: 16183292 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease. Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459 [TBL] [Abstract][Full Text] [Related]
5. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors. Asadipour A; Alipour M; Jafari M; Khoobi M; Emami S; Nadri H; Sakhteman A; Moradi A; Sheibani V; Homayouni Moghadam F; Shafiee A; Foroumadi A Eur J Med Chem; 2013; 70():623-30. PubMed ID: 24211638 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics. Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease. Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289 [TBL] [Abstract][Full Text] [Related]
8. Novel N-benzylpiperidine derivatives of 5-arylisoxazole-3-carboxamides as anti-Alzheimer's agents. Saeedi M; Felegari P; Iraji A; Hariri R; Rastegari A; Mirfazli SS; Edraki N; Firuzi O; Mahdavi M; Akbarzadeh T Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000258. PubMed ID: 33226157 [TBL] [Abstract][Full Text] [Related]
9. Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease. de Andrade P; Mantoani SP; Gonçalves Nunes PS; Magadán CR; Pérez C; Xavier DJ; Hojo ETS; Campillo NE; Martínez A; Carvalho I Bioorg Med Chem; 2019 Mar; 27(6):931-943. PubMed ID: 30765302 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates. Dias Viegas FP; de Freitas Silva M; Divino da Rocha M; Castelli MR; Riquiel MM; Machado RP; Vaz SM; Simões de Lima LM; Mancini KC; Marques de Oliveira PC; Morais ÉP; Gontijo VS; da Silva FMR; D'Alincourt da Fonseca Peçanha D; Castro NG; Neves GA; Giusti-Paiva A; Vilela FC; Orlandi L; Camps I; Veloso MP; Leomil Coelho LF; Ionta M; Ferreira-Silva GÁ; Pereira RM; Dardenne LE; Guedes IA; de Oliveira Carneiro Junior W; Quaglio Bellozi PM; Pinheiro de Oliveira AC; Ferreira FF; Pruccoli L; Tarozzi A; Viegas C Eur J Med Chem; 2018 Mar; 147():48-65. PubMed ID: 29421570 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo. Więckowska A; Więckowski K; Bajda M; Brus B; Sałat K; Czerwińska P; Gobec S; Filipek B; Malawska B Bioorg Med Chem; 2015 May; 23(10):2445-57. PubMed ID: 25868744 [TBL] [Abstract][Full Text] [Related]
12. New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease. Czarnecka K; Girek M; Maciejewska K; Skibiński R; Jończyk J; Bajda M; Kabziński J; Sołowiej P; Majsterek I; Szymański P J Enzyme Inhib Med Chem; 2017 Dec; 33(1):158-170. PubMed ID: 29210299 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase. Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949 [TBL] [Abstract][Full Text] [Related]
14. Design and Synthesis of Novel Arylisoxazole-Chromenone Carboxamides: Investigation of Biological Activities Associated with Alzheimer's Disease. Saeedi M; Rastegari A; Hariri R; Mirfazli SS; Mahdavi M; Edraki N; Firuzi O; Akbarzadeh T Chem Biodivers; 2020 May; 17(5):e1900746. PubMed ID: 32154628 [TBL] [Abstract][Full Text] [Related]
15. Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis. Khan I; Ibrar A; Zaib S; Ahmad S; Furtmann N; Hameed S; Simpson J; Bajorath J; Iqbal J Bioorg Med Chem; 2014 Nov; 22(21):6163-73. PubMed ID: 25257911 [TBL] [Abstract][Full Text] [Related]
16. Search for new multi-target compounds against Alzheimer's disease among histamine H Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B Eur J Med Chem; 2020 Jan; 185():111785. PubMed ID: 31669851 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors. Razavi SF; Khoobi M; Nadri H; Sakhteman A; Moradi A; Emami S; Foroumadi A; Shafiee A Eur J Med Chem; 2013 Jun; 64():252-9. PubMed ID: 23644208 [TBL] [Abstract][Full Text] [Related]